Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
16,886
+45
+0.3% +$5.27K 0.14% 110
2026
Q1
$2.03M Sell
16,841
-1,974
-10% -$228K 0.14% 100
2025
Q4
$1.98M Sell
18,815
-2,877
-13% -$270K 0.13% 102
2025
Q3
$1.82M Buy
21,692
+1,444
+7% +$119K 0.12% 107
2025
Q2
$1.6M Sell
20,248
-1,448
-7% -$115K 0.12% 113
2025
Q1
$1.95M Sell
21,696
-9,663
-31% -$902K 0.16% 92
2024
Q4
$3.12M Sell
31,359
-15,418
-33% -$1.59M 0.25% 63
2024
Q3
$5.31M Sell
46,777
-8,212
-15% -$976K 0.36% 54
2024
Q2
$6.81M Buy
54,989
+293
+0.5% +$37.7K 0.47% 44
2024
Q1
$7.25M Buy
54,696
+758
+1% +$93.4K 0.54% 36
2023
Q4
$5.89M Buy
53,938
+459
+0.9% +$47.6K 0.48% 44
2023
Q3
$5.53M Buy
53,479
+821
+2% +$88.5K 0.47% 43
2023
Q2
$6.09M Buy
52,658
+573
+1% +$65.1K 0.52% 39
2023
Q1
$5.54M Sell
52,085
-1,142
-2% -$123K 0.51% 40
2022
Q4
$5.91M Buy
53,227
+3,953
+8% +$404K 0.6% 31
2022
Q3
$4.25M Buy
49,274
+10,462
+27% +$934K 0.47% 42
2022
Q2
$3.53M Buy
38,812
+3,215
+9% +$285K 0.52% 40
2022
Q1
$2.92M Buy
35,597
+5,383
+18% +$424K 0.33% 70
2021
Q4
$2.32M Buy
30,214
+2,815
+10% +$224K 0.28% 83
2021
Q3
$2.07M Buy
27,399
+56
+0.2% +$4.26K 0.27% 84
2021
Q2
$2.12M Buy
27,343
+7,259
+36% +$540K 0.32% 83
2021
Q1
$1.49M Sell
20,084
-9,784
-33% -$722K 0.34% 80
2020
Q4
$2.33M Sell
29,868
-920
-3% -$70.4K 0.46% 56
2020
Q3
$2.42M Buy
30,788
+10,930
+55% +$856K 0.53% 50
2020
Q2
$1.46M Buy
19,858
+1,685
+9% +$127K 0.4% 68
2020
Q1
$1.33M Sell
18,173
-7,255
-29% -$570K 0.4% 68
2019
Q4
$2.2M Buy
25,428
+3,306
+15% +$272K 0.62% 48
2019
Q3
$1.77M Buy
22,122
+864
+4% +$69.2K 0.59% 47
2019
Q2
$1.69M Buy
21,258
+991
+5% +$75.9K 0.55% 48
2019
Q1
$1.6M Buy
20,267
+1,825
+10% +$136K 0.56% 50
2018
Q4
$1.35M Buy
18,442
+2,948
+19% +$208K 0.55% 51
2018
Q3
$1.05M Buy
15,494
+1,716
+12% +$109K 0.39% 77
2018
Q2
$789K Buy
13,778
+1,092
+9% +$61.6K 0.27% 101
2018
Q1
$662K Sell
12,686
-3,695
-23% -$200K 0.33% 81
2017
Q4
$880K Sell
16,381
-3,966
-19% -$220K 0.35% 81
2017
Q3
$1.23M Buy
20,347
+1,155
+6% +$70K 0.59% 52
2017
Q2
$1.16M Sell
19,192
-61
-0.3% -$3.71K 0.58% 51
2017
Q1
$1.15M Sell
19,253
-320
-2% -$19.4K 0.62% 48
2016
Q4
$1.09M Buy
19,573
+4,657
+31% +$273K 0.63% 52
2016
Q3
$875K Buy
14,916
+527
+4% +$30.8K 0.55% 55
2016
Q2
$781K Buy
14,389
+108
+0.8% +$5.75K 0.54% 53
2016
Q1
$721K Buy
14,281
+935
+7% +$45.8K 0.53% 60
2015
Q4
$673K Buy
+13,346
New +$673K 0.44% 72

Other funds holding MRK

Asset Dedication LLC's MRK Position: Q2 2026 in Review

Asset Dedication LLC increased its Merck (MRK) stake by 0.27% in Q2 2026, buying an estimated $5.27K and bringing the position to 16,886 shares worth $2.17M. The position accounts for 0.14% of the portfolio, ranked #110.

Asset Dedication LLC first reported a position in MRK in Q4 2015 and has held it in 43 quarters since. The position peaked at $7.25M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Asset Dedication LLC held 16,886 shares of Merck worth $2.17M as of Q2 2026.
  • Asset Dedication LLC bought 45 Merck shares in Q2 2026, an estimated $5.27K.
  • Merck made up 0.14% of Asset Dedication LLC's portfolio in Q2 2026, its #110 holding.
  • Asset Dedication LLC first reported a position in Merck in Q4 2015 and has held it in 43 quarters since.
  • Asset Dedication LLC's Merck position peaked at $7.25M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.